Sponsored by Merck & Co., Inc.
The global vaccine marketplace has seen considerable change over the last decade. Many of the “easier” diseases with clear development and regulatory pathways and well-defined patient populations have been developed and available.
This impressive panel of vaccine industry leaders will discuss the future of the global vaccine business. Panelists will discuss the opportunities and challenges, from helping drive access in middle income countries to industry’s role in addressing vaccine hesitancy, facing vaccine developers and manufacturers and the importance of continued innovation in vaccines.
Session ID: 228185